What To Expect in 2027
Groundbreaking advancements in Treg space have provided the potential to redefine how we treat autoimmune, inflammatory and neurodegenerative diseases.
Yet, with this surging momentum, many questions in the community remain unanswered. The Treg-Directed Therapy Summit unites the world’s leading minds to begin to answer the questions that remain in Treg biology understanding, novel therapeutic modalities, indication selection, therapeutic endpoints, patient selection, clinical trial design, clinical data and more.
At the only meeting dedicated exclusively to Treg therapies, attendees will engage with a 35% c-suite speaker faculty as they shared unseen data, strategies and unmatched actionable insights to fast-track your therapeutic success.
Explore the 2026 Event Guide
- A streamlined, single-track agenda so you can catch every session
- The Treg Biology Focus Day to deepen mechanistic insights & accelerate translational impact
- 9 hours of networking, to be on a first-name basis with experts in the Treg community
- C-suite led panel discussions revealing real-world strategies and perspectives from the industry's top decision makers
- Exclusive new data presentations
- A 75% new speaker faculty, bringing fresh perspectives to the stage
Attending Companies Include
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.